One of the challenges in investing in the high-beta small biotech sector is dealing with FDA decisions that don't always go the way you want them toA lot of times the actual ruling is not as bad as investors initially think, as wellI have learned over the years to not make knee-jerk reactions to these decisionsKeeping calm and analyzing the situat...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.